This photo shows an Ozempic medicine box, an injectable anti-diabetic drug, in a pharmacy. Sebastien Bozon/AFP via Getty Images Hide caption
Toggle caption Sebastien Bozon/AFP via Getty Images
This photo shows an Ozempic medicine box, an injectable anti-diabetic drug, in a pharmacy.
Sebastien Bozon/AFP via Getty Images
For the first time in decades, obesity rates in the United States are not increasing.
Adult obesity rates have fallen from 41.9% in 2020 to about 40% in 2023, according to the CDC’s latest National Health and Nutrition Examination Survey.
Although the study does not identify the sole reason for this change, its timing coincides with the emergence of new classes of drugs targeting diabetes and weight loss, such as Ozempic and Wegovy.
As part of our series “It’s Good for You,” we discuss these new drugs and the decline in obesity rates.
Find more of our programs online. Listen to 1A without a sponsor by signing up for 1A+ at plus.npr.org/the1a.
